Real-World Studies
Mandard TRG linked to survival in gastroesophageal adenocarcinoma cohort
Puhr et alESMO gastrointestinal oncology
In a 19-year retrospective cohort study of 692 patients with locally advanced, resectable gastroesophageal adenocarcinoma treated between 2006 and 2024 at the Medical University of Vienna, researchers assessed the clinical and prognostic relevance of tumor regression grade (TRG) following neoadjuvant systemic therapy. Among the 394 patients who received neoadjuvant systemic therapy, 175 had documented TRG classified by Mandard, Becker, or both criteria.
Pathological evaluation revealed marked heterogeneity in tumor regression, with a predominance of poor responders. Lower TRG scores were strongly associated with lower ypT and ypN stages, as well as the absence of lymphatic, venous, and perineural invasion (all P < 0.05). In survival analyses, Mandard TRG demonstrated a statistically significant association with both disease-free survival (P = 0.03) and overall survival (P = 0.0015). Conversely, Becker TRG was not significantly associated with survival endpoints.
Despite the prognostic signal observed with Mandard TRG, classical post-neoadjuvant pathological parameters—including ypT, ypN, venous invasion (ypV), perineural invasion (ypPn), and resection margin status (R)—remained the strongest overall prognostic determinants. The specific neoadjuvant treatment strategy employed was also associated with TRG scores. The study noted that definitive multivariable survival modeling was constrained by event numbers and missing data.
Key Takeaways
- Mandard tumor regression grade demonstrated significant prognostic association with disease-free survival (P = 0.03) and overall survival (P = 0.0015), whereas Becker tumor regression grade showed no statistically significant association with survival outcomes.
- Lower tumor regression scores were significantly correlated with favorable ypT and ypN categories and the absence of lymphatic, venous, and perineural invasion (all P < 0.05), although classical pathological factors (ypT, ypN, ypV, ypPn, and resection margin status) remained the primary prognostic determinants.
Read the original sourceESMO gastrointestinal oncology
